|
William H. Fleming, Ph.D. was named Chief Scientific Officer of QuantRx in July 2005. He also serves as a Director and the Secretary of the company; a position he has held since 1994. He was the Company’s Vice President of Diagnostics from 1997 through July 2005 and Acting CEO from 2003 until May 2005. He was President and Chief Operating Officer from 1994 to 1997. Dr. Fleming was President, Chief Operating Officer and a Director of ProFem until its merger with QuantRx in June 1994. Dr. Fleming was also affiliated with Sovereign Ventures, a healthcare consulting firm, and concurrently served as Director of Corporate Development of Antivirals, Inc., a biotechnology company involved in antisense technology. Dr. Fleming is a Director of ERC, a non-profit company. | 